Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL386450 | 0.89 | GPR119 (1.00) | GPR119 | |
| SCHEMBL388346 | 0.89 | GPR119 (1.00) | GPR119 | |
| SCHEMBL5048689 | 0.84 | GPR119 (0.66) | GPR119PIK3CD | |
| SCHEMBL27755048 | 0.75 | GPR119 (0.58) | GPR119PIK3CD | |
| SCHEMBL389479 | 0.73 | GPR119 (0.73) | GPR119 | |
| SCHEMBL4456614 | 0.73 | GPR119 (0.73) | GPR119 | |
| SCHEMBL1244926 | 0.72 | GPR119 (0.50) | GPR119 | |
| SCHEMBL3285206 | 0.71 | GPR119 (0.65) | GPR119 | |
| SCHEMBL288589 | 0.71 | GPR119 (0.80) | GPR119 | |
| SCHEMBL3811610 | 0.70 | GPR119 (0.49) | GPR119PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2292620-A2 | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prohylaxis and treatment of disorders related thereto | Arena Pharmaceuticals, Inc. (US) | 2011-03-09 | — | — | EP | disclosed |
| EP-2287166-A2 | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto | Arena Pharmaceuticals, Inc. (US) | 2011-02-23 | — | — | EP | disclosed |
| EP-2287165-A2 | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto | Arena Pharmaceuticals, Inc. (US) | 2011-02-23 | — | — | EP | disclosed |